Sugi Predict

Sugi Predict / Compounds / SCHEMBL18878104

SCHEMBL18878104

SCHEMBL18878104

C[C@H]1NC(=O)c2cc(F)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.42
▸ NTRK1 P04629 4/20 0.42
▸ PARP1 P09874 2/20 0.39
▸ PARP10 Q53GL7 1/20 0.39
▸ PARP2 Q9UGN5 1/20 0.38
▸ CCNE2 O96020 2/20 0.37
▸ CCNE1 P24864 2/20 0.37
▸ CDK2 P24941 2/20 0.37
▸ MKNK1 Q9BUB5 1/20 0.37
▸ MKNK2 Q9HBH9 1/20 0.37
▸ CREBBP Q92793 1/20 0.36
▸ FABP6 P51161 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CA7 P43166 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ LRRK2 Q5S007 1/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ JAK2 O60674 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18863238 1.00 ACHE (0.42) ACHENTRK1PARP1PARP10PARP2
SCHEMBL18878150 1.00 ACHE (0.42) ACHENTRK1PARP1PARP10PARP2
SCHEMBL12241449 0.79 KDM4E (0.44) ACHEPARP1PARP10MKNK1MKNK2
SCHEMBL12241460 0.79 KDM4E (0.44) ACHEPARP1PARP10MKNK1MKNK2
SCHEMBL12240953 0.79 KDM4E (0.44) ACHEPARP1PARP10MKNK1MKNK2
SCHEMBL14992148 0.78 PPOX (0.46) PARP1PARP10MKNK1MKNK2HTR2C
SCHEMBL12219994 0.78 MKNK2 (0.40) MKNK1MKNK2CA1CA2CA9
SCHEMBL2904093 0.78 CYP1A2 (0.42) PARP1PARP10MKNK1MKNK2CA1
SCHEMBL16098250 0.78 CYP1A2 (0.42) PARP1PARP10MKNK1MKNK2CA1
SCHEMBL29676714 0.78 CYP1A2 (0.42) PARP1PARP10MKNK1MKNK2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820759-B2 Modulators of chemokine receptors CHEMOCENTRYX, INC. (US) 2023-11-21 — — US disclosed
US-11820759-B2 Modulators of chemokine receptors CHEMOCENTRYX, INC. (US) 2023-11-21 — — US disclosed
US-20220009912-A1 MODULATORS OF CHEMOKINE RECEPTORS CHEMOCENTRYX, INC. 2022-01-13 — — US disclosed
US-20220009911-A1 INHIBITORS OF CXCR2 CHEMOCENTRYX, INC. 2022-01-13 — — US disclosed
US-11040960-B2 Inhibitors of CXCR2 CHEMOCENTRYX, INC. (US) 2021-06-22 — — US disclosed
US-10988464-B2 Modulators of chemokine receptors CHEMOCENTRYX, INC. (US) 2021-04-27 — — US disclosed
EP-3377059-B1 INHIBITORS OF CXCR2 CHEMOCENTRYX INC (US) 2020-10-21 — — EP disclosed
US-20200140418-A1 INHIBITORS OF CXCR2 CHEMOCENTRYX, INC. 2020-05-07 — — US disclosed
US-20200039969-A1 MODULATORS OF CHEMOKINE RECEPTORS CHEMOCENTRYX, INC. 2020-02-06 — — US disclosed
US-10370363-B2 Inhibitors of CXCR2 CHEMOCENTRYX, INC. (US) 2019-08-06 — — US disclosed
US-20180170916-A1 INHIBITORS OF CXCR2 CHEMOCENTRYX, INC. 2018-06-21 — — US disclosed
US-20180141934-A1 MODULATORS OF CHEMOKINE RECEPTORS CHEMOCENTRYX, INC. 2018-05-24 — — US disclosed
US-9834545-B2 Modulators of chemokine receptors CHEMOCENTRYX, INC. (US) 2017-12-05 — — US disclosed
US-9834545-B2 Modulators of chemokine receptors CHEMOCENTRYX, INC. (US) 2017-12-05 — — US disclosed
US-9809581-B2 Inhibitors of CXCR2 CHEMOCENTRYX, INC. (US) 2017-11-07 — — US disclosed
US-9809581-B2 Inhibitors of CXCR2 CHEMOCENTRYX, INC. (US) 2017-11-07 — — US disclosed
US-20170144996-A1 INHIBITORS OF CXCR2 CHEMOCENTRYX, INC. 2017-05-25 — — US disclosed
US-20170144996-A1 INHIBITORS OF CXCR2 CHEMOCENTRYX, INC. 2017-05-25 — — US disclosed
US-20170144997-A1 MODULATORS OF CHEMOKINE RECEPTORS CHEMOCENTRYX, INC. 2017-05-25 — — US disclosed
US-20170144997-A1 MODULATORS OF CHEMOKINE RECEPTORS CHEMOCENTRYX, INC. 2017-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10988464-B2 Modulators of chemokine receptors CCR5, CXCR3, CCR2 ACHE 4820/4885NTRK1 485/4885PARP1 3322/4885
US-20220009911-A1 INHIBITORS OF CXCR2 CXCR2, CXCR3, CXCR1 ACHE 4872/4885NTRK1 3898/4885PARP1 3337/4885
US-20200039969-A1 MODULATORS OF CHEMOKINE RECEPTORS CCR5, CXCR3, CCR2 ACHE 4820/4885NTRK1 485/4885PARP1 3322/4885
US-20170144997-A1 MODULATORS OF CHEMOKINE RECEPTORS CCR5, CXCR3, CCR2 ACHE 4820/4885NTRK1 485/4885PARP1 3322/4885
US-20170144996-A1 INHIBITORS OF CXCR2 CXCR2, CXCR3, CXCR1 ACHE 4872/4885NTRK1 3898/4885PARP1 3337/4885
US-20200140418-A1 INHIBITORS OF CXCR2 CXCR2, CXCR3, CXCR1 ACHE 4872/4885NTRK1 3898/4885PARP1 3337/4885
US-11820759-B2 Modulators of chemokine receptors CCR5, CXCR3, CCR2 ACHE 4820/4885NTRK1 485/4885PARP1 3322/4885
US-10370363-B2 Inhibitors of CXCR2 CXCR2, CXCR3, CXCR1 ACHE 4872/4885NTRK1 3898/4885PARP1 3337/4885
US-20180141934-A1 MODULATORS OF CHEMOKINE RECEPTORS CCR5, CXCR3, CCR2 ACHE 4820/4885NTRK1 485/4885PARP1 3322/4885
US-11040960-B2 Inhibitors of CXCR2 CXCR2, CXCR3, CXCR1 ACHE 4872/4885NTRK1 3898/4885PARP1 3337/4885
US-20220009912-A1 MODULATORS OF CHEMOKINE RECEPTORS CCR5, CXCR3, CCR2 ACHE 4820/4885NTRK1 485/4885PARP1 3322/4885
US-20180170916-A1 INHIBITORS OF CXCR2 CXCR2, CXCR3, CXCR1 ACHE 4872/4885NTRK1 3900/4885PARP1 3337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.